PLGAI 002
Alternative Names: PLGAI-002Latest Information Update: 31 Mar 2025
At a glance
- Originator Peptilogics
- Class Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified
Most Recent Events
- 12 Mar 2025 Early research in Unspecified in USA (unspecified route) prior to March 2025 (Peptilogics pipeline, March 2025)